Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents: update on new stimulant preparations, atomoxetine, and novel treatments.
about
European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHDAn update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorderThe noradrenergic action in antidepressant treatments: pharmacological and clinical aspectsNew developments in the pharmacotherapy of cocaine abuseDescription and Demonstration of CBT for ADHD in Adults.Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics.Noradrenergic regulation of glial activation: molecular mechanisms and therapeutic implications.Attention-deficit-hyperactivity disorder: an update.Effects of omeprazole on the pharmacokinetic profiles of lisdexamfetamine dimesylate and extended-release mixed amphetamine salts in adults.Dissociation between spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats in baseline performance and methylphenidate response on measures of attention, impulsivity and hyperactivity in a Visual Stimulus Position Discrimination Task.Drug therapy of attention deficit hyperactivity disorder: current trends.Transfer of dexamphetamine into breast milk during treatment for attention deficit hyperactivity disorder.Cognitive-behavioural therapy in medication-treated adults with attention-deficit/hyperactivity disorder and co-morbid psychopathology: a randomized controlled trial using multi-level analysis.Innovations and recent trends in the treatment of ADHD.The pharmacogenomic era: promise for personalizing attention deficit hyperactivity disorder therapy.Isolation rearing as a preclinical model of attention/deficit-hyperactivity disorderSwitching from oral extended-release methylphenidate to the methylphenidate transdermal system: continued attention-deficit/hyperactivity disorder symptom control and tolerability after abrupt conversion.Developmental context and treatment principles for ADHD among college students.Expert Opinion and Recommendations for the Management of Attention-Deficit/Hyperactivity Disorder in Correctional Facilities.A prospective observational study of attention-deficit/hyperactivity disorder in Central and Eastern Europe and Turkey: Symptom severity and treatment options in a paediatric population.A 12-month prospective, observational study of treatment regimen and quality of life associated with ADHD in central and eastern europe and eastern Asia.Detecting and treating adult attention deficit hyperactivity disorder in a patient with schizophrenia.A non-interventional study of extended-release methylphenidate in the routine treatment of adolescents with ADHD: effectiveness, safety and adherence to treatment.
P2860
Q21260332-9C19EC83-662F-433F-931F-876E1C40D560Q28246274-4958B4FA-C0F5-4A1C-81C6-4138F86075B0Q28300843-120C95F7-0B70-44FB-A2CB-00DE4E00A598Q28302782-31111D52-3E43-459B-A27E-2957F314A129Q30560858-6B530A23-D96E-4953-9A79-A8CF6ECD13C3Q33870580-E579BABE-DF2E-46F1-A798-F84EAF59E26CQ34391616-D59C4F12-4910-4C6B-BC39-AEFCDAE1E25BQ34983475-BA9EB0FB-9B5A-4726-929F-E076D312CEE7Q35007442-6B2CCC42-065B-4D95-AF80-B60AF8C78D5CQ35329653-E5F58830-00D9-49C4-BE5D-D71A9AB73F03Q35964370-D66FD1E3-7322-4DA3-86EA-BB0A203F9752Q36024999-DBE05AF1-CC8C-4DA0-A6D3-2E6ECFB328A7Q36129274-1169D3E7-5669-4D7C-8A9C-58202265D4A2Q36607357-A6686FCA-E26B-4769-9610-5838B12E8C93Q36699910-95B51A2A-52FD-497A-8DBB-68A693311346Q36912231-FD58DB34-049B-4A27-AB73-CA672A75B0ABQ37419717-754BC3A1-AF1D-445D-9618-F1AD0416937DQ38051039-E80EC9F3-1C19-415D-A69C-CC4740DE27A9Q40207289-444838C3-BB04-40F3-999B-FDB24323A061Q44950209-E8D39884-43DB-4C98-B6CC-2589CB242D32Q48786713-01ABB35F-4CCA-488B-974D-A91A0D798AE7Q50642927-9E5A3510-60BF-4C7C-A939-393AE15FE17EQ50703835-2E8FC533-B3DC-4105-983E-C27FF18E9AC5
P2860
Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents: update on new stimulant preparations, atomoxetine, and novel treatments.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Pharmacotherapy of attention-d ...... oxetine, and novel treatments.
@ast
Pharmacotherapy of attention-d ...... oxetine, and novel treatments.
@en
type
label
Pharmacotherapy of attention-d ...... oxetine, and novel treatments.
@ast
Pharmacotherapy of attention-d ...... oxetine, and novel treatments.
@en
prefLabel
Pharmacotherapy of attention-d ...... oxetine, and novel treatments.
@ast
Pharmacotherapy of attention-d ...... oxetine, and novel treatments.
@en
P921
P1476
Pharmacotherapy of attention-d ...... oxetine, and novel treatments.
@en
P2093
Jefferson B Prince
P356
10.1016/J.CHC.2005.08.002
P577
2006-01-01T00:00:00Z